Menu
Scroll to Top
Vian Therapeutics is a visionary virtual pharma startup at the forefront of combating microvascular retinal diseases. Focused on conditions like Diabetic Retinopathy and Age-Related Macular Degeneration, we're pioneering a novel solution: Vian-C4551, a groundbreaking cyclic peptide drug delivered via convenient eyedrop administration. By swiftly stabilizing retinal blood vessels, our non-invasive approach aims to halt vision deterioration earlier than traditional methods (e.g., intraocular injections). With millions affected, Vian Therapeutics aims to redefine ocular care, offering hope for clearer sight and a brighter future of retinal health.
Something looks off?